Purpose: To identify individuals at-risk for T1D and offer close monitoring for disease progression as well as potential prevention study opportunities.
For more information visit TrialNet on the web.
Study Cordinator: Juanita O'Brian, NRCMA
Contact: usfdiabetesresearchc@usf.edu
Purpose: To prevent or delay disease progression in Stage 1 Type 1 individuals (2 or more auto-antibodies and normal glucose tolerance).
Study Coordinator: Juanita O'Brian, NRCMA
Contact: usfdiabetesresearchc@usf.edu
Purpose: To prevent or delay disease progression in Stage 1 Type 1 individuals (2 or more auto-antibodies and normal glucose tolerance).
Study Coordinator: Juanita O'Brian, NRCMA
Contact: usfdiabetesresearchc@usf.edu
Purpose: To preserve insulin production by preventing beta cell destruction in individuals newly diagnosed with T1D.
Study Coordinator: Ponja Hemphill, RN
Contact: usfdiabetesresearchc@usf.edu
Purpose: To determine whether an investigational drug called Teplizumab may help preserve insulin production in children and adolescents who were recently diagnosed with Type 1 Diabetes
Study Coordinator: Ponja Hemphill, RN
Contact: usfdiabetesresearchc@usf.edu
Purpose: To evaluate the safety of non-adjunctive CGM use in CGM naive participants, by assessing the number of hypoglycemic and diabetic ketoacidosis (DKA) events with use of CGM
Study Coordinator: Janet Rodriguez, BSN, RN, CDCES, CRA-USF/BASIC
Contact: usfdiabetesresearchc@usf.edu
Purpose: To test the safety and effectiveness of Linagliptin in combination with Empagliflozin (FDA approved for treatment of type 2 adults) in pediatric type 2 patients.
Study Coordinator: Janet Rodriguez, BSN, RN, CDCES, CRA-USF/BASIC
Contact: usfdiabetesresearchc@usf.edu
TEDDY Study compares characteristics of children diagnosed with type 1 diabetes before and after age 6
New findings from the international The Environmental Determinants of Diabetes in the Young (TEDDY) study add to the growing body of evidence indicating that type 1 diabetes is not a single disease.
Click here to view full article.
USF Awarded Four-Year, $69.9 Million NIH Grant to Continue Type 1 Diabetes Research
The Environmental Determinants of Diabetes in the Young study is led by USF Health’s Jeffrey Krischer, who has built a worldwide epidemiological hub for T1D research at USF.
Click here to view full article.
Nature highlights USF Health-led TEDDY study as a diabetes research milestone
Click here to view article.
USF Health Informatics Institute contributes to new NIH study indicating that measuring gene expression changes over time may help predict type 1 diabetes progression in at-risk children, and lead to earlier diagnosis of the autoimmune disease.
Click here to read the full article.
USF Diabetes Center Focuses on Pathway to Prevention
How Can I Help Find A Way to Prevent Type 1 Diabetes?